SPEAKERS

Updates In Breast Cancer: Morgan Cantley, PharmD, BCOP

Morgan Cantley is a board-certified oncology clinical pharmacist with a passion for breast cancer as well as safe and clinically appropriate medication use across the oncology spectrum. Through her experiences at various academic medical centers, she has successfully implemented and managed major workflow changes, chemotherapy protocol builds, and relationships between fellow pharmacists, nurses, advanced practice providers, and physicians. Morgan graduated from the Medical University of South Carolina with her PharmD in 2020 (COVID grad!). She then completed a PGY1 pharmacy practice residency at Atrium Health Wake Forest Baptist followed by PGY2 hematology/oncology residency at the University of Kentucky. Following residency, she established a clinical pharmacist presence supporting oncology fellows and solid tumor teams in the outpatient setting at Virginia Commonwealth University. She transitioned into her new role at McKesson in January of 2024 working remotely with a USON- affiliated community oncology practice to ensure safe and effective chemotherapy and immunotherapy use across a large spectrum of disease states.

Precision Medicine in Oncology: Amber Cipriani, PharmD, BCOP

Amber Cipriani is a clinical pharmacist specialized in oncology care and pharmacogenomics. She currently serves as the Precision Medicine Pharmacy Coordinator at the University of North Carolina Medical Center where she works to implement initiatives that improve medication use and management through the utilization of technology, genetics, and clinical decision support tools. She is a member of the Molecular Tumor Board and Precision Oncology Program. She serves as the leader of the Pharmacogenomics Initiative of the Program for Precision Medicine in Health Care (PPMH) at UNC. Dr. Cipriani’s position is a joint funded position with the UNC Eshelman School of Pharmacy, where she serves as a Clinical Assistant Professor coordinates elective courses in pharmacogenomics and hematology/oncology pharmacotherapy for professional PharmD students.

BiSpecifics: Onboarding and Managing Toxicities: Rebekah Dyer, PharmD, BCPS

Rebekah Dyer, PharmD, BCPS is an oncology clinical specialist for the Cellular Immunotherapies and Transplant (CIT) program at VCU Health in Richmond, Virginia. Her primary practice site is the ambulatory clinic, where started February 2024. Prior to VCU Health, she spent 7 years at a local community hospital working in various clinical pharmacy specialist roles including inpatient staffing, outpatient infusion, and ambulatory hematology / oncology. Rebekah earned her bachelor’s in biomedical sciences from Auburn University, followed by her PharmD from the Harrison College of Pharmacy at Auburn University. She completed her PGY1 at Piedmont Columbus Regional Hospital in Columbus, Georgia, prior to moving to Virginia. Rebekah is originally from Mobile, Alabama, and spends her free time with family and friends, enjoying local cuisine, and cheering on all the family favorite sports teams.

Precision Oncology in Practice: Transforming Non–Small Cell Lung Cancer Care Through Advanced Biomarker Testing: Stefanie Houseknecht, PharmD, BCOP

Stefanie Houseknecht, Pharm.D., BCOP, is a clinical pharmacy specialist in oncology. She earned a doctorate of pharmacy degree at the University of the Pacific, Thomas J. Long School of Pharmacy and Pharmaceutical Sciences. After graduation, she completed an acute care PGY-1 pharmacy practice residency at Palomar Medical Center in Escondido, CA followed by a PGY-2 oncology residency at the University of California-San Diego (UCSD). She currently works at Johns Hopkins Hospital and Bayview Medical Center as a clinical pharmacy specialist in ambulatory thoracic malignancies. Her role is to improve access to oral targeted therapies, assist with the management of toxicities from these agents, and improve outcomes for patients with lung cancer. She is an active member of the Education Committee of the International Association for the Study of Lung Cancer (IASLC) and precepts pharmacy students and residents from schools in the Baltimore and greater mid-Atlantic area.

New Drug Update: Michael LaPorte, PharmD

Michael LaPorte, PharmD is a clinical pharmacy specialist for the malignant hematology and stem cell services at the University of Virginia in Charlottesville. Michael earned his doctorate of pharmacy degree at the University of Virginia School of Pharmacy in 2022. After graduation, he completed a PGY-1 residency at Sentara RMH Medical Center in Harrisonburg, VA followed by a PGY-2 oncology residency at Roswell Park Comprehensive Cancer Center.

Developing the Individual Learner: A Focus on the Human Aspects of Precepting: Andrew Whitman, PharmD, BCOP

Dr. Whitman is the current residency program director for PGY2 Oncology Pharmacy program and serves as the Lead Clinical Pharmacist for Oncology/Hematology. His primary practice site is the inpatient solid tumor service. He serves as the main preceptor for the PGY2 oncology supportive/palliative care rotation and also precepts PGY1 residents. He received a combined PharmD and Certificate of Aging Studies from Virginia Commonwealth University (VCU) School of Pharmacy in 2014. He then completed his PGY1 and PGY2 Oncology Pharmacy Residency at the University of Virginia Health from 2014-2016. His main research interests include deprescribing in older adults with cancer and the use of medical cannabis for symptom management; additionally, he has a growing interest in the medical use of psychedelic compounds. Dr. Whitman was recognized with the VCU Outstanding Preceptor award for 2019-2020 and the 2021-2022 UVA Pharmacy Residency Preceptor of the Year Award.